Villard L - Search Results

1

Modification of Mecp2 dosage alters axonal transport through the Huntingtin/Hap1 pathway.

Roux JC, Zala D, Panayotis N, Borges-Correia A, Saudou F, Villard L. Roux JC, et al. Among authors: villard l. Neurobiol Dis. 2012 Feb;45(2):786-95. doi: 10.1016/j.nbd.2011.11.002. Epub 2011 Nov 15. Neurobiol Dis. 2012. PMID: 22127389

2

Mecp2 deficiency disrupts norepinephrine and respiratory systems in mice.

Viemari JC, Roux JC, Tryba AK, Saywell V, Burnet H, Peña F, Zanella S, Bévengut M, Barthelemy-Requin M, Herzing LB, Moncla A, Mancini J, Ramirez JM, Villard L, Hilaire G. Viemari JC, et al. Among authors: villard l. J Neurosci. 2005 Dec 14;25(50):11521-30. doi: 10.1523/JNEUROSCI.4373-05.2005. J Neurosci. 2005. PMID: 16354910 Free PMC article.

3

Brain magnetic resonance study of Mecp2 deletion effects on anatomy and metabolism.

Saywell V, Viola A, Confort-Gouny S, Le Fur Y, Villard L, Cozzone PJ. Saywell V, et al. Among authors: villard l. Biochem Biophys Res Commun. 2006 Feb 17;340(3):776-83. doi: 10.1016/j.bbrc.2005.12.080. Epub 2005 Dec 20. Biochem Biophys Res Commun. 2006. PMID: 16380085

4

[Noradrenaline deficiency as the origin of respiratory disorders in Rett syndrome an animal model].

Villard L, Roux JC. Villard L, et al. Med Sci (Paris). 2006 Jan;22(1):81-3. doi: 10.1051/medsci/200622181. Med Sci (Paris). 2006. PMID: 16386227 Free article. French. No abstract available.

5

MECP2 mutations in males.

Villard L. Villard L. J Med Genet. 2007 Jul;44(7):417-23. doi: 10.1136/jmg.2007.049452. Epub 2007 Mar 9. J Med Genet. 2007. PMID: 17351020 Free PMC article. Review.

6

Treatment with desipramine improves breathing and survival in a mouse model for Rett syndrome.

Roux JC, Dura E, Moncla A, Mancini J, Villard L. Roux JC, et al. Among authors: villard l. Eur J Neurosci. 2007 Apr;25(7):1915-22. doi: 10.1111/j.1460-9568.2007.05466.x. Eur J Neurosci. 2007. PMID: 17439480

7

[Pharmacological treatment of Rett syndrome improves breathing and survival in a mouse model].

Roux JC, Villard L. Roux JC, et al. Among authors: villard l. Med Sci (Paris). 2007 Oct;23(10):805-7. doi: 10.1051/medsci/20072310805. Med Sci (Paris). 2007. PMID: 17937887 Free article. French. No abstract available.

8

Expression of methyl CpG binding protein 2 (Mecp2) during the postnatal development of the mouse brainstem.

Dura E, Villard L, Roux JC. Dura E, et al. Among authors: villard l. Brain Res. 2008 Oct 21;1236:176-84. doi: 10.1016/j.brainres.2008.08.021. Epub 2008 Aug 16. Brain Res. 2008. PMID: 18761004

9

Tyrosine hydroxylase deficit in the chemoafferent and the sympathoadrenergic pathways of the Mecp2 deficient mouse.

Roux JC, Dura E, Villard L. Roux JC, et al. Among authors: villard l. Neurosci Lett. 2008 Dec 5;447(1):82-6. doi: 10.1016/j.neulet.2008.09.045. Epub 2008 Sep 24. Neurosci Lett. 2008. PMID: 18834926

10

Spatiotemporal expression in mouse brain of Kiaa2022, a gene disrupted in two patients with severe mental retardation.

Cantagrel V, Haddad MR, Ciofi P, Andrieu D, Lossi AM, Maldergem Lv, Roux JC, Villard L. Cantagrel V, et al. Among authors: villard l. Gene Expr Patterns. 2009 Sep;9(6):423-9. doi: 10.1016/j.gep.2009.06.001. Epub 2009 Jun 11. Gene Expr Patterns. 2009. PMID: 19524067

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

201 results

Search Page